Yuxin Jin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yuxin Jin has a total of 131 co-authors. Here are the top co-authors by number of shared publications:
- John D. Carpten
City of Hope, Beckman Research Institute, Department of Integrative Translational Sciences
29 shared publications - Jing Qian
University of Southern California
28 shared publications - Rania Bassiouni
Beckman Research Institute, City of Hope
28 shared publications - David Wesley Craig
Beckman Research Institute, City of Hope
27 shared publications - Lynda D. Roman
University of Southern California
27 shared publications - Heather Miller
University of Southern California 2 Department of Translational Genomics, Keck School of Medicine Los Angeles, California
26 shared publications
Latest Publications
- Open Access
- 22 October 2026
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 22 (10) , e1012355
Multi-omics analysis of high-grade serous ovarian cancers reveals heterogeneity and distinct immunological patterns based upon clinico-genomic status
High-grade serous ovarian cancer (HGSOC) is characterized by remarkable intratumoral heterogeneity and variable tissue architectures, dictating differential therapeutic responses. Although BRCA1/2 mutations correlate with improved responses to DNA-damaging agents, how BRCA genotype shapes the tumor immune microenvironment (TIME) remains incompletely understood. Here, we integrated whole exome sequencing, total RNA sequencing and spatial transcriptomics to profile a cohort of BRCA-mutated (BRCA-MT) and non-BRCA-mutated (BRCA-WT) HGSOC tumors. While bulk transcriptomics highlighted global phenotypic shifts, suggesting a more pro-inflammatory milieu in BRCA-MT tumors, spatially resolved analysis revealed how these differences manifest within specific tissue architectures. Integrated clustering revealed recurrent spatial transcriptional states across genotypes. Specifically, we identified a transcriptionally distinct immune-enriched region (IC7) characterized by low tumor purity, interferon signaling, and antigen-presentation programs. Reference-based RCTD deconvolution provided orthogonal computational support that IC7 was enriched for T/NK and dendritic cells relative to non-IC7 regions. At the patient level, the functional state of IC7 was highly BRCA-dependent: BRCA-MT tumors exhibited stronger enrichment of interferon-α/γ responses and inflammatory signaling than BRCA-WT tumors. Exploratory CellChat analysis further suggested genotype-associated differences in predicted immune-related signaling. We also identify a conserved structural interface between CAF-like region (IC3) and macrophage-rich region (IC4), accompanied by a predicted CXCL12–CXCR4 chemokine recruitment axis. Taken together, these findings support a model in which BRCA mutation status is associated with functional differences within broadly conserved spatial regions, rather than extensive reorganization of the overall spatial architecture. This spatially resolved framework identifies BRCA-associated immune transcriptional patterns in HGSOC and provides a basis for future mechanistic validation.
- 22 October 2026
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 22 (10) , e1012355
Open AccessMulti-omics analysis of high-grade serous ovarian cancers reveals heterogeneity and distinct immunological patterns based upon clinico-genomic status
High-grade serous ovarian cancer (HGSOC) is characterized by remarkable intratumoral heterogeneity and variable tissue architectures, dictating differential therapeutic responses. Although BRCA1/2 mutations correlate with improved responses to DNA-damaging agents, how BRCA genotype shapes the tumor immune microenvironment (TIME) remains incompletely understood. Here, we integrated whole exome sequencing, total RNA sequencing and spatial transcriptomics to profile a cohort of BRCA-mutated (BRCA-MT) and non-BRCA-mutated (BRCA-WT) HGSOC tumors. While bulk transcriptomics highlighted global phenotypic shifts, suggesting a more pro-inflammatory milieu in BRCA-MT tumors, spatially resolved analysis revealed how these differences manifest within specific tissue architectures. Integrated clustering revealed recurrent spatial transcriptional states across genotypes. Specifically, we identified a transcriptionally distinct immune-enriched region (IC7) characterized by low tumor purity, interferon signaling, and antigen-presentation programs. Reference-based RCTD deconvolution provided orthogonal computational support that IC7 was enriched for T/NK and dendritic cells relative to non-IC7 regions. At the patient level, the functional state of IC7 was highly BRCA-dependent: BRCA-MT tumors exhibited stronger enrichment of interferon-α/γ responses and inflammatory signaling than BRCA-WT tumors. Exploratory CellChat analysis further suggested genotype-associated differences in predicted immune-related signaling. We also identify a conserved structural interface between CAF-like region (IC3) and macrophage-rich region (IC4), accompanied by a predicted CXCL12–CXCR4 chemokine recruitment axis. Taken together, these findings support a model in which BRCA mutation status is associated with functional differences within broadly conserved spatial regions, rather than extensive reorganization of the overall spatial architecture. This spatially resolved framework identifies BRCA-associated immune transcriptional patterns in HGSOC and provides a basis for future mechanistic validation.
- Open Access
- 5 October 2026
- Published by American Society of Hematology in Blood
African Genetic Similarity Is Associated with Reduced Inflammation and Enhanced Adaptive Immunity in Multiple Myeloma
The bone marrow immune microenvironment (BMME) is a critical factor in multiple myeloma (MM) pathogenesis. Despite higher incidence of MM among self-identified African Americans, the relationship between African genetic similarity and the BMME remains unclear. We present the largest analysis to date assessing the impact of Ancestry on the BMME in myeloma (N=320, including 64 with ≥50% African genetic similarity, AFR-High) leveraging our recently generated Immune Atlas. AFR-High was associated with enrichment of late T-effector cells, driven by rare cytotoxic CD4⁺ T cells, suggesting a distinct adaptive BMME. AFR-High exhibited expansion of late-differentiated adaptive NK cells with high cytotoxic GNLY and GZMH expression. AFR-High depicted reduced CD14⁺ monocytes, increased CD16⁺ non-classical monocytes, and expansion of macrophage-like monocyte populations with enrichment of metabolic adaptation, efferocytosis and phagocytic clearance programs, and immunoregulatory pathways. These findings reveal a shift from an innate inflammatory immune landscape toward adaptive cytotoxic and immunoregulatory remodeling associated with African genetic similarity in MM.
- 5 October 2026
- Published by American Society of Hematology in Blood
Open AccessAfrican Genetic Similarity Is Associated with Reduced Inflammation and Enhanced Adaptive Immunity in Multiple Myeloma
The bone marrow immune microenvironment (BMME) is a critical factor in multiple myeloma (MM) pathogenesis. Despite higher incidence of MM among self-identified African Americans, the relationship between African genetic similarity and the BMME remains unclear. We present the largest analysis to date assessing the impact of Ancestry on the BMME in myeloma (N=320, including 64 with ≥50% African genetic similarity, AFR-High) leveraging our recently generated Immune Atlas. AFR-High was associated with enrichment of late T-effector cells, driven by rare cytotoxic CD4⁺ T cells, suggesting a distinct adaptive BMME. AFR-High exhibited expansion of late-differentiated adaptive NK cells with high cytotoxic GNLY and GZMH expression. AFR-High depicted reduced CD14⁺ monocytes, increased CD16⁺ non-classical monocytes, and expansion of macrophage-like monocyte populations with enrichment of metabolic adaptation, efferocytosis and phagocytic clearance programs, and immunoregulatory pathways. These findings reveal a shift from an innate inflammatory immune landscape toward adaptive cytotoxic and immunoregulatory remodeling associated with African genetic similarity in MM.
- Open Access
- 18 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from Integrated Single-Cell Whole-Genome Sequencing and Spatial Transcriptomics Reveal Intratumoral Heterogeneity in Ovarian Cancer
Copy number inferred from OV440 ST data
- 18 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 from Integrated Single-Cell Whole-Genome Sequencing and Spatial Transcriptomics Reveal Intratumoral Heterogeneity in Ovarian Cancer
Copy number inferred from OV440 ST data
- Open Access
- 18 June 2026
- Published by American Association for Cancer Research (AACR)
Figure 7 from Integrated Single-Cell Whole-Genome Sequencing and Spatial Transcriptomics Reveal Intratumoral Heterogeneity in Ovarian Cancer
Unique evolutionary history in a multiclonal CCOC. A, Average CN profiles for clusters 2 and 3 of OV511. Shading represents SD. B, DAPC analysis applied to the subclusters of OV511. C, Subcluster phylogeny of OV511. Cluster 1 was specified as the outgroup and is displayed in negative evolutionary space for visualization purposes. D, VAFs for select somatic mutations shared by clusters 2 and 3 of OV511. E, BAF in 100 Kb blocks across chromosome 3 for OV511 clusters 2 and 3. The CTNNB1 locus is annotated. F, Single-cell allele-specific CNs and inferred LOH for sample OV511. LOH is represented by black shading. The arrow marks the location of a mirrored convergent evolution event on chromosome 10. At this region, cluster 2 has two copies of the B allele and one copy of the A allele, whereas cluster 3 has one copy of the B allele and two copies of the A allele. Both clusters thus have an absolute CN of 3. The dotted box highlights the LOH on chromosome 3 that results in CTNNB1 wild-type (WT) reversion. G, Hematoxylin and eosin–stained tissue section of OV511. The square denotes the 11 mm × 11 mm area captured by the Visium assay. H, Spatial map and UMAP of ST spots determined to represent clusters 2 and 3 by positional gene set enrichment. I, Aggregate enrichment scores for ST annotations in H, as determined by single-sample GSEA against the Hallmark gene sets. The mean of each group is annotated by a horizontal line. All plots shown have a Bonferroni-corrected P value < 0.0001. J, Hypothesized evolutionary trajectory for sample OV511. Somatic CTNNB1 mutation is the oncogenic driver and is followed by a WGD event. Two main branches are distinguished by unique CNA, including mirrored allelic imbalance on chromosome 10. A parallel evolution event drives similar subclonal alterations before cluster 2 diverges with a unique set of CNAs, including loss of the CTNNB1 mutation. DF, discriminant function.
- 18 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure 7 from Integrated Single-Cell Whole-Genome Sequencing and Spatial Transcriptomics Reveal Intratumoral Heterogeneity in Ovarian Cancer
Unique evolutionary history in a multiclonal CCOC. A, Average CN profiles for clusters 2 and 3 of OV511. Shading represents SD. B, DAPC analysis applied to the subclusters of OV511. C, Subcluster phylogeny of OV511. Cluster 1 was specified as the outgroup and is displayed in negative evolutionary space for visualization purposes. D, VAFs for select somatic mutations shared by clusters 2 and 3 of OV511. E, BAF in 100 Kb blocks across chromosome 3 for OV511 clusters 2 and 3. The CTNNB1 locus is annotated. F, Single-cell allele-specific CNs and inferred LOH for sample OV511. LOH is represented by black shading. The arrow marks the location of a mirrored convergent evolution event on chromosome 10. At this region, cluster 2 has two copies of the B allele and one copy of the A allele, whereas cluster 3 has one copy of the B allele and two copies of the A allele. Both clusters thus have an absolute CN of 3. The dotted box highlights the LOH on chromosome 3 that results in CTNNB1 wild-type (WT) reversion. G, Hematoxylin and eosin–stained tissue section of OV511. The square denotes the 11 mm × 11 mm area captured by the Visium assay. H, Spatial map and UMAP of ST spots determined to represent clusters 2 and 3 by positional gene set enrichment. I, Aggregate enrichment scores for ST annotations in H, as determined by single-sample GSEA against the Hallmark gene sets. The mean of each group is annotated by a horizontal line. All plots shown have a Bonferroni-corrected P value < 0.0001. J, Hypothesized evolutionary trajectory for sample OV511. Somatic CTNNB1 mutation is the oncogenic driver and is followed by a WGD event. Two main branches are distinguished by unique CNA, including mirrored allelic imbalance on chromosome 10. A parallel evolution event drives similar subclonal alterations before cluster 2 diverges with a unique set of CNAs, including loss of the CTNNB1 mutation. DF, discriminant function.
- Open Access
- 18 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from Integrated Single-Cell Whole-Genome Sequencing and Spatial Transcriptomics Reveal Intratumoral Heterogeneity in Ovarian Cancer
Copy number and LOH at chromosomes 13 and 17 in OV440
- 18 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from Integrated Single-Cell Whole-Genome Sequencing and Spatial Transcriptomics Reveal Intratumoral Heterogeneity in Ovarian Cancer
Copy number and LOH at chromosomes 13 and 17 in OV440
- Open Access
- 18 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary File 2 from Integrated Single-Cell Whole-Genome Sequencing and Spatial Transcriptomics Reveal Intratumoral Heterogeneity in Ovarian Cancer
Cell-level single cell whole genome sequencing metrics and cluster assignments.
- 18 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary File 2 from Integrated Single-Cell Whole-Genome Sequencing and Spatial Transcriptomics Reveal Intratumoral Heterogeneity in Ovarian Cancer
Cell-level single cell whole genome sequencing metrics and cluster assignments.
- Open Access
- 18 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary File 3 from Integrated Single-Cell Whole-Genome Sequencing and Spatial Transcriptomics Reveal Intratumoral Heterogeneity in Ovarian Cancer
Assessment of two models of OV511 evolution
- 18 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary File 3 from Integrated Single-Cell Whole-Genome Sequencing and Spatial Transcriptomics Reveal Intratumoral Heterogeneity in Ovarian Cancer
Assessment of two models of OV511 evolution